Your browser doesn't support javascript.
loading
Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer.
Tai, YunYan; Cao, Fengjun; Li, Mingxing; Li, Pindong; Xu, Tao; Wang, Xuanbin; Yu, Yuandong; Gu, Bing; Yu, Xiongjie; Cai, Xiaojun; Ao, Feng; Ge, Peng; Xiang, Longchao; Yang, Bingbing; Jiang, Yingpin; Li, Yong.
Afiliação
  • Tai Y; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Cao F; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Li M; Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan, Hubei 430030, P.R.China.
  • Li P; Cancer Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R.China.
  • Xu T; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Wang X; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China; Laboratory of Chinese Herbal Pharmacology, Oncology Center, Renmin Hospital, Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, Shiyan, Hubei 442000, P.R
  • Yu Y; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China; Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R.China.
  • Gu B; Department of Oncology, Danjiangkou First Hospital, Danjiangkou, Hubei 442700, P.R.China.
  • Yu X; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Cai X; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Ao F; Department of Medical Imaging Center, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Ge P; Department of Medical Imaging Center, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Xiang L; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Yang B; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Jiang Y; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China.
  • Li Y; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China; Institute of Cancer Research, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R.China. Electronic address: studyong@hust.edu.cn.
Redox Biol ; 20: 451-457, 2019 01.
Article em En | MEDLINE | ID: mdl-30439686
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Assunto principal: Piruvatos / Interferon gama / Espécies Reativas de Oxigênio / Neoplasias do Colo / Mitocôndrias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Redox Biol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Assunto principal: Piruvatos / Interferon gama / Espécies Reativas de Oxigênio / Neoplasias do Colo / Mitocôndrias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Redox Biol Ano de publicação: 2019 Tipo de documento: Article